Please login to the form below

Not currently logged in
Email:
Password:

Protein degraders

This page shows the latest Protein degraders news and features for those working in and with pharma, biotech and healthcare.

Amgen and Plexium announce new research collaboration worth over $500m

Amgen and Plexium announce new research collaboration worth over $500m

The main focus of the partnership is to expand opportunities for targeted protein degradation through the discovery of previously unrecognised molecular glues or monovalent degraders. ... We look forward to working with Amgen to accelerate the discovery

Latest news

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Can protein degraders unlock ‘undruggable’ drug targets? Can protein degraders unlock ‘undruggable’ drug targets?

    as well as upstream regulators that control protein stability and abundance, and ways to disrupt protein-protein interactions that could also activate degradation pathways. ... in this area, either through in-house projects or collaborations with protein

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...